List of Affimed patents

List of Affimed patents

List of Venafi patents

List of PostProcess Technologies, Inc. patents

List of Fungible, Inc. patents

List of SBIR/STTR awards granted to Structural Analytics, Inc.

List of funding rounds for KRY (company)

Patents where

Current Assignee

Name

is

Affimed

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9035026 Anti-CD16 binding molecules	Patent 9035026 was granted and assigned to Affimed on May, 2015 by the United States Patent and Trademark Office.		Affimed		United States Patent and Trademark Office	9035026	May 19, 2015
	‌ US Patent 9226962 Human CD3-specific antibody with immunosuppressive properties	Patent 9226962 was granted and assigned to Affimed on January, 2016 by the United States Patent and Trademark Office.	Affimed Therapeutics	Affimed		United States Patent and Trademark Office	9226962	January 5, 2016
	‌ US Patent 9701750 Anti-CD16 binding molecules	Patent 9701750 was granted and assigned to Affimed on July, 2017 by the United States Patent and Trademark Office.	Affimed	Affimed		United States Patent and Trademark Office	9701750	July 11, 2017
	‌ US Patent 11510972 Bispecific EGFR/CD16 antigen-binding protein	Patent 11510972 was granted and assigned to Affimed on November, 2022 by the United States Patent and Trademark Office.	Affimed	Affimed		United States Patent and Trademark Office	11510972	November 29, 2022
	‌ US Patent 11572415 Multivalent FV antibodies		Affimed	Affimed		United States Patent and Trademark Office	11572415	February 7, 2023
	‌ US Patent 11535672 Combination of an anti-CD16A antibody with a cytokine		Affimed	Affimed		United States Patent and Trademark Office	11535672	December 27, 2022
	‌ US Patent 11001633 NK cell engaging antibody fusion constructs	Patent 11001633 was granted and assigned to Affimed on May, 2021 by the United States Patent and Trademark Office.	Affimed	Affimed		United States Patent and Trademark Office	11001633	May 11, 2021
	‌ US Patent 11167029 Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy	Patent 11167029 was granted and assigned to Affimed on November, 2021 by the United States Patent and Trademark Office.	Affimed	Affimed		United States Patent and Trademark Office	11167029	November 9, 2021
	‌ US Patent 11180558 Tandem diabody for CD16A-directed NK-cell engagement	Patent 11180558 was granted and assigned to Affimed on November, 2021 by the United States Patent and Trademark Office.	Affimed	Affimed		United States Patent and Trademark Office	11180558	November 23, 2021
	‌ US Patent 12076384 Bispecific EGFR/CD16 antigen-binding protein	Patent 12076384 was granted and assigned to Affimed on September, 2024 by the United States Patent and Trademark Office.	Affimed	Affimed		United States Patent and Trademark Office	12076384	September 3, 2024

10 results

0 selected

10 results

0 selected